DOI: 10.12890/2026_006600
Whipple’s disease complicated by severe pulmonary hypertension and right ventricular failure
Authors
abdulrahman.karam@outlook.com
Keywords
Whipple’s disease, pulmonary hypertension, ventricular failureAbstract
Whipple’s disease is a rare, chronic systemic infection caused by Tropheryma whipplei that commonly presents with gastrointestinal manifestations but may involve multiple extraintestinal organs. Cardiac involvement, particularly culture-negative endocarditis, is described; however, pulmonary complications such as pulmonary hypertension (PH) are uncommon. We report a case of Whipple’s disease presenting with severe pre-capillary pulmonary hypertension and right ventricular (RV) failure with reversibility following antimicrobial therapy. A 62-year-old woman with seropositive rheumatoid arthritis on adalimumab, presented with one month of profuse watery diarrhoea, abdominal pain, dizziness and weakness. Imaging revealed diffuse mesenteric and para-aortic lymphadenopathy. Upper endoscopy demonstrated oedematous whitish granular villi in the duodenum, and biopsies showed periodic acid–Schiff–positive, acid-fast bacillus–negative foamy macrophages diagnostic of Whipple’s disease. Transthoracic echocardiography revealed RV dilation and dysfunction with pulmonary hypertension, which was confirmed on right heart catheterisation as severe pre-capillary PH with elevated pulmonary vascular resistance and normal wedge pressure. The patient developed RV-predominant cardiogenic shock requiring inotropic and vasopressor support. Following initiation of intravenous ceftriaxone her haemodynamics improved rapidly, with normalisation of cardiac output and marked reduction in pulmonary pressures on repeat catheterisation. Gastrointestinal symptoms resolved, immunosuppressive therapy was discontinued, and she was discharged on prolonged antimicrobial therapy. This case underscores PH as a rare but potentially reversible manifestation of Whipple’s disease. Recognition of this entity is critical, as PH-specific vasodilator therapy alone is often ineffective, whereas early targeted antimicrobial treatment can result in rapid and profound clinical and haemodynamic recovery, even in cases presenting with severe RV failure.
References
- Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp 1907;18:382–393.
- Marth T, Raoult D. Whipple’s disease. Lancet 2003;361:239-246. doi: 10.1016/S0140-6736(03)12274-X
- Geissdörfer W, Moos V, Moter A, Loddenkemper C, Jansen A, Tandler R, et al. High frequency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol 2012;50:216–222. doi: 10.1128/JCM.05531-11
- Villa A, Nucera G, Kostihova A, Mazzola A, Marino P. Reversible pulmonary hypertension associated with Whipple’s disease. Case Rep Pulmonol 2012;2012:382460. doi: 10.1155/2012/382460
- Baloira A, Núñez M, Tumbeiro M, Parente-Lamelas I, Bastos M, Gutiérrez M. Pulmonary hypertension associated with Whipple disease. Eur Respir Rev 2014;23:533–536. doi: 10.1183/09059180.00005714
- Morrison DA, Gay RG, Feldshon D, Sampliner RE. Severe pulmonary hypertension in a patient with Whipple’s disease. Am J Med 1985;79:263–267. doi: 10.1016/0002-9343(85)90020-8
- Lyle PL, Weber RD, Bogarin J, Kircher T. Reversible pulmonary hypertension in Whipple disease: a case report with clinicopathological implications and literature review. BMJ Case Rep 2009;2009:bcr06.2008.0095. doi: 10.1136/bcr.06.2008.0095
- Camboulive A, Jutant EM, Savale L, Jaïs X, Sitbon O, Mussini C, et al. Reversible pulmonary hypertension associated with multivisceral Whipple’s disease. Eur Respir J 2021;57:2003132. doi: 10.1183/13993003.03132-2020
- Hoskote SS, Georgescu A, Ganjhu L, Zeizafoun N, Polsky B. Resolution of Whipple disease-induced pulmonary hypertension following antibiotic therapy. Am J Ther 2014;21:e143-e147. doi: 10.1097/MJT.0b013e3182691cdc
- Peschard S, Brinkane A, Bergheul S, Crickx L, Gaudin B, Morcelet M, et al. Maladie de Whipple associée à une hypertension artérielle pulmonaire. Réaction de Jarisch-Herxheimer après antibiothérapie [Whipple disease associated with pulmonary arterial hypertension. Jarisch-Herxheimer reaction after antibiotic therapy]. Presse Med 2001;30:1549–1551. French.
- Zahra SA, McCabe C, Price L, Brown MM, Nashat H, Wort SJ. 7-043 Pulmonary hypertension and Whipple’s disease: a diagnostic challenge. Heart 2025;111:A240–A241. doi: 10.1136/heartjnl-2025-BCS.234
- Riemer H, Hainz R, Stain C, Dekan G, Feldner-Busztin M, Schenk P, et al. Severe pulmonary hypertension reversed by antibiotics in a patient with Whipple’s disease. Thorax 1997;52:1014–1015. doi: 10.1136/thx.52.11.1014.
- Jutant EM, Roche A, Boucly A, Camboulive A, Jevnikar M, Jaïs X, et al. Whipple’s disease: a rare and life-threatening cause of pulmonary hypertension. Eur Respir J 2021;58:PA3599. doi: 10.1183/13993003.congress-2021.PA3599
- Najm S, Hajjar J, Nelson RP Jr, Moorthy RS, Wolf KM, Lahm T. Whipple’s disease-associated pulmonary hypertension with positive vasodilator response despite severe hemodynamic derangements. Can Respir J 2011;18(5):e70–e72. doi: 10.1155/2011/365645